COMPANY

Conifer Point Pharmaceuticals LLC

HQ: Doylestown, PA source · coniferpoint.com ↗

Conifer Point Pharmaceuticals provides computational chemistry and biology services to nonprofit, academic, and industrial researchers involved in drug discovery and development. From company website Source · Oct 13, 2026

Keywords: pharmaceuticals drug discovery

Location: Doylestown, PA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1M (SBIR Phase II 5R44GM109549-05, continuation, notice Jun 23, 2026). NIH RePORTER 5R44GM109549-05 (Jun 23, 2026)
Evidence (1 event)
- Jun 23, 2026 · NIH RePORTER 5R44GM109549-05
  Organization: CONIFER POINT PHARMACEUTICALS, LLC; City/State: DOYLESTOWN, PA; Project number: 5R44GM109549-05; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-23; FY total cost (award amount): 1000000; Administering IC: National Institute of General Medical Sciences; Project title: An Open Web Service For Fragment-based Design of Small Molecule Inhibitors; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jun 23, 2026 Grant Government grant — SBIR: $1M (annual award, as published), announced Jun 23, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Jun 3, 2025 Grant Government grant — SBIR: $1.05M (annual award, as published), announced Jun 3, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗

Funding

Last 2 years.

Jun 23, 2026 Government grant — SBIR: $1M (annual award, as published), announced Jun 23, 2026. Agency: NIH/NIGMS. Source: government award database. source ↗
Jun 3, 2025 Government grant — SBIR: $1.05M (annual award, as published), announced Jun 3, 2025. Agency: NIH/NIGMS. Source: government award database. source ↗

Connect

Contact page